Our results also demonstrate the effects of TLR7 deficiency and impaired IFN/ISG responses on lung virus titers, antiviral/inflammatory responses, and pulmonary damage, all of which could not be evaluated in COVID-19 patients because of the lack of human autopsy or lung biopsy samples. This evidence concerns the gene TLR7 and COVID-19.